NR 293 Week 3 Quiz | Chamberlain | Pharmacology
Basics | Latest Exam | Verified Answers
Comprehensive Pharmacology Week 3 Quiz for Nursing
Students
⬇ INSTANT DOWNLOAD ⬇
Format: Q&A + Rationales + Why-Wrong Graded: A+ / Guaranteed Pass
Updated: 2026 (Latest NR 293 Guidelines) Questions: 295
Comprehensive NR 293 Week 3 Quiz Review — Every question includes a detailed rationale and a full
explanation of why each incorrect option is wrong. Based on the Chamberlain NR 293 Week 3
Pharmacology content.
295 VERIFIED QUESTIONS AND ANSWERS · EVIDENCE-BASED RATIONALES · WHY-WRONG
EXPL ANATIONS FOR EVERY OPTION
What This Exam Covers 295 Questions
This comprehensive NR 293 Week 3 Quiz pharmacology review is aligned with the
Chamberlain University pharmacology curriculum. It covers all essential topics for
nursing students, including:
Central Nervous System Anticonvulsants: Phenytoin,
Drugs: Antidepressants (SSRIs, SNRIs, carbamazepine, valproic acid,
TCAs, MAOIs), antipsychotics (typical levetiracetam, and other antiepileptic
drugs.
, and atypical), anxiolytics, and mood
stabilizers.
Antiparkinson Drugs: Levodopa- Sedative-
carbidopa, dopamine agonists, Hypnotics: Benzodiazepines, non-
anticholinergics, and MAO-B benzodiazepine sleep aids
inhibitors. (zolpidem), and barbiturates.
Pain Management: Opioid Anti-inflammatory
analgesics, non-opioid analgesics, Drugs: Corticosteroids, NSAIDs, and
NSAIDs, and adjuvant therapies. DMARDs.
Immunosuppressants: Drugs used Drug Interactions: Important
in autoimmune disorders and interactions between CNS drugs and
transplant patients. other medications.
Nursing Adverse Effects: Common and
Considerations: Assessment, serious adverse effects of CNS and
monitoring, patient education, and pain management drugs.
adverse effect management.
Patient Education: Teaching points Special Populations: Considerations
for patients receiving these for geriatric, pediatric, and pregnant
medications. patients.
Why Download This Exam?
Guaranteed Pass: Master the content tested on the NR 293 Week 3 Quiz with
295 carefully crafted questions that cover every major topic.
Learn from Mistakes: Each incorrect option is explained in detail so you
understand why it is wrong, not just why the correct answer is right.
Exam Readiness: Build confidence by practicing with questions that mirror the
real pharmacology quiz format and difficulty level.
Time-Saving: All the essential content is consolidated into one document —
no need to search through multiple resources.
Instant Download: Access the material immediately and start studying right
away.
, You will pass your NR 293 Week 3 Quiz on your first attempt with this
comprehensive review!
NR293 PHARMACOLOGY CHAMBERLAIN WEEK3 VERIFIEDQANDA
GRADEDA+ RATIONALES WHYWRONG GUARANTEEDPASS LATEST2026
1.
A patient is prescribed sertraline for depression. Which of the following is the
mechanism of action for this medication?
A. Blocks dopamine receptors
B. Inhibits serotonin reuptake
C. Inhibits norepinephrine reuptake
D. Blocks acetylcholine receptors
Correct Answer: B
Rationale: Sertraline is a selective serotonin reuptake inhibitor (SSRI) that inhibits the
reuptake of serotonin, increasing its concentration in the synaptic cleft.
Why the other options are wrong:
A. Blocks dopamine receptors — Blocking dopamine receptors is the mechanism for
antipsychotics.
C. Inhibits norepinephrine reuptake — Inhibiting norepinephrine reuptake is the
mechanism for SNRIs and some TCAs.
D. Blocks acetylcholine receptors — Blocking acetylcholine receptors is the
mechanism for anticholinergic drugs.
Reference: NR 293 Week 3, Antidepressants.
2.
A patient is prescribed phenytoin for seizures. Which of the following lab values
should the nurse monitor to detect potential toxicity?
A. Serum phenytoin level
B. Serum creatinine
C. AST and ALT
D. Complete blood count
Correct Answer: A
, Rationale: Phenytoin has a narrow therapeutic index, and serum levels should be
monitored to prevent toxicity.
Why the other options are wrong:
B. Serum creatinine — Serum creatinine is used to monitor renal function, not
phenytoin levels.
C. AST and ALT — AST and ALT are used to monitor liver function, not phenytoin
levels.
D. Complete blood count — CBC is not specific to phenytoin monitoring.
Reference: NR 293 Week 3, Anticonvulsants.
3.
A patient is prescribed levodopa-carbidopa for Parkinson's disease. Which of the
following is the purpose of adding carbidopa to levodopa?
A. To increase dopamine release
B. To prevent peripheral conversion of levodopa to dopamine
C. To increase the half-life of levodopa
D. To reduce the side effects of levodopa
Correct Answer: B
Rationale: Carbidopa prevents the peripheral conversion of levodopa to dopamine,
allowing more levodopa to reach the brain and reducing peripheral side effects.
Why the other options are wrong:
A. To increase dopamine release — Carbidopa does not increase dopamine release.
C. To increase the half-life of levodopa — Carbidopa does not significantly increase
the half-life of levodopa.
D. To reduce the side effects of levodopa — Carbidopa reduces peripheral side effects
but does not eliminate central side effects.
Reference: NR 293 Week 3, Antiparkinson Drugs.
4.
A patient is prescribed an atypical antipsychotic. Which of the following metabolic
side effects is most concerning with long-term use?